Kurt Azarbarzin is Director at TELA Bio, Inc. (TELA). They have made 1 open-market trade across 1 company since 2019, most recently 2025-05-28.
CIK 0001792303
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1.1M since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TELA | 18,470 | $18K |
Shares reported on the most recent Form 4, priced at the 2025-05-30 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TELA | BUY | 2019-11-08 | 2019-11-13 | $13.00 | $1.1M | -6.0% | -7.0% | +24.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.